Viral Proteases as Targets for Drug Design

By  

Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. : 1126-1153

Bentham Science Publishers

Access to resources Recommend Favorite

X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?

By Topiol Sid  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 607-620

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to flavivirus drug discovery

By Botting Carolyn   Kuhn Richard J  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 417-428

Informa Healthcare

Access to resources Recommend Favorite

On the Active Site Protonation State in Aspartic Proteases: Implications for Drug Design

By  

Current Pharmaceutical Design, Vol. 19, Iss. 23, 2013-07 ,pp. : 4257-4275

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery

By  

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 501-526

Bentham Science Publishers

Access to resources Recommend Favorite